Does Lemon Water Help You Lose Weight? No. And It Doesn’t Alkalise You Either.

No.

But do not leave yet, because lemon juice has been put to a proper test for one thing — keeping kidney stones from coming back — and what that test found is worth knowing. It is just not about your waist, and not about most of the people drinking it.

The water question is a different page

Let us clear the ground first. Some of what people notice from lemon water is simply what happens when you drink a glass of water before you eat, and there is modest randomised evidence for that.

We took that apart separately in does drinking water help you lose weight — short version: the famous metabolism boost is about 24 calories and the best attempt to replicate it failed, but drinking water before meals has two small trials behind it and costs nothing.

None of that is about lemons. So this page is about the lemon.

The alkaline claim, and why we do not need to argue about blood

The central promise of the morning lemon water ritual is that it alkalises you. Lemon is acidic going in, the story goes, but it leaves an alkaline residue, and shifting your body toward alkaline is supposed to do everything from burning fat to preventing disease.

The usual rebuttal is a lecture about how your blood pH is held between 7.35 and 7.45 by your lungs and kidneys and does not care what you had for breakfast. That rebuttal is correct. It is also unnecessary, because there is a much shorter way home.

Somebody measured it.

A 2021 review gathered thirteen studies of citrus juices and kidney stones: ten small studies that measured urine chemistry — urine being where an alkalising effect, if it existed, would actually show up — and three large population studies of who went on to form stones. The finding, verbatim: “Only orange and grapefruit juices had an alkalinizing effect and while lemon juice has a protective effect by raising urinary citrate levels, it lacked a significant alkalinizing effect on urine pH[1].

That summary gets grapefruit wrong, by the review’s own numbers. Its data table shows no significant rise in urine pH in any of the three grapefruit studies it includes, and none for lime [1]. One of the grapefruit studies, which we read in full, says it plainly: on about a pint or a quart of grapefruit juice a day (0.5 or 1.0 litre), urine pH rose only slightly, and “the differences were not statistically significant” [5].

Now read it again, with the table. Orange juice alkalised. Grapefruit and lime did not. Lemon did not. And in a two-year randomised trial of fresh lemon juice in 203 people, urine pH never differed between those drinking it and those who were not [6].

So you do not have to win the argument about whether alkalising your body is a coherent goal. Take the theory entirely at face value, go and measure the one number it points at, and lemon fails its own test. The ritual picked the wrong fruit.

Now the part researchers actually tested

Here is what lemon juice might do. Urologists have been testing it against kidney stones since at least 1996 [7], while the wellness industry was busy with the other thing.

Lemon is loaded with citrate. And citrate in urine is one of the body’s own defences against calcium kidney stones — it binds calcium before it can crystallise. People who form stones are often low in it, a condition with the unlovely name hypocitraturia.

Researchers put a range of drinks through nuclear magnetic resonance to find out which actually carry citrate [2].

Citrate, measured by NMR · mmol per litre
Grapefruit juice 64.7
Lemon juice 47.66
Orange juice 47.36
Crystal Light lemonade, from powder 38.39
Homemade lemonade 17.42
Diet 7Up 7.98
Haleblian 2008. The powdered stuff carries more than twice the citrate of the homemade version.

Note the two rows we have highlighted. Lemon juice is near the top. And homemade lemonade came in at 17.42, well under half the powdered Crystal Light at 38.39 [2] — presumably because a home recipe is mostly water and sugar around a small squeeze. The artificial-looking option is the stronger one, which is not how this is supposed to go.

How good is the evidence that it prevents stones?

Better than you would guess, and weaker than the headlines. Both.

The famous paper is a 2007 study of “lemonade therapy”. It is cited everywhere, and here is what it actually was: a retrospective look at patients, of whom exactly eleven met the criteria, compared with eleven matched patients on prescription potassium citrate [3].

Urinary citrate did rise on lemonade — by 383 mg a day, which was statistically significant. Prescription potassium citrate raised it more, by 482 [3].

The number that travels is that stone formation fell from 1.00 to 0.13 stones per patient per year. What almost nobody repeats is the note beside it: p > 0.05 [3]. Not statistically significant. Neither was the change in stone burden. In eleven people, that is exactly what you would expect — and the authors say plainly that a randomised trial is needed.

In 2022 came the kind of trial those authors asked for. In Bergamo, Italy, 203 adults who kept forming calcium oxalate stones, about two in three of them men, were all put on the same stone-prevention diet, and half were randomly assigned to add about 2 fl oz (60 mL) of fresh lemon juice twice a day, for two years. Nobody got a placebo; the other half simply went without, and every new stone had to be confirmed on an ultrasound scan read by a doctor who did not know who was drinking the juice. The one in six who were low in urinary citrate also took prescription potassium citrate, in both groups [6].

Stones came back in 21 of the 100 on lemon juice and 32 of the 103 without it. That looks like a cut of about a third, but it could still be chance. The hazard ratio — the risk of a new stone on lemon juice relative to the risk without it — was 0.62, and the range the true answer probably sits in ran from 0.35, a large benefit, to 1.07, none at all [6]. The authors think falling adherence weakened the result: 79% of the lemon group were drinking it as told at six months, 48% at two years. An analysis they chose after the fact, stopped at one year, did find a clear difference, 10 recurrences against 22, and they call it exploratory. Their own conclusion is that the findings are “not robust enough to recommend oral juice supplementation in everyday clinical practice” [6].

Two more results matter for anyone reading this page. Urinary citrate, the thing lemon juice is supposed to raise, did not rise, and urine pH never differed between the groups. And one person in five on lemon juice got heartburn, against one in a hundred without it [6].

In January 2026 an evidence review commissioned by the US Agency for Healthcare Research and Quality weighed that trial. It graded the evidence that lemon juice cuts recurrence as “low for at least a small benefit”, and the evidence that it causes side effects, mostly heartburn and stomach pain, as “low for at least a small harm”. Low, in the agency’s own definition, means “limited confidence that the estimate of effect lies close to the true effect”. Judging daily citrate as a whole — citrate salts such as prescription potassium citrate, and lemon juice — it lowered its grade from the moderate of its previous review to low [8]. Its search ran to May 2025, and it listed a two-year trial of a lime-powder supplement from Thailand as published only in abstract form [8].

A full report of such a trial appeared in December 2025. It tested a very different product from lemon juice, and reported a much bigger effect. A double-blind randomised placebo-controlled trial across six hospitals in Thailand followed 173 patients who had just had calcium oxalate stones removed, for two years [4].

Recurrence — a new stone, or a leftover fragment growing past 4 mm (about a sixth of an inch), seen on x-ray or CT scans — was 14% on the lime supplement against 45% on placebo: a hazard ratio of 0.24, with a range of plausible answers from 0.13 to 0.44 [4]. That is a large effect. It is also one trial, not yet repeated, and it counted stones seen on scans rather than stones that caused symptoms.

Four documented details bear on how much weight it can carry. The trial registration number printed in the paper leads to a different trial: a six-month study of a lime extract for kidney disease in people with diabetes, which began enrolling in July 2021 [9]. The closest registration we found, on ClinicalTrials.gov, is for a lime-powder stone trial that differs from the published one in size (137 people, not 173), blinding (participants only, not double-blind), dosing (twice a day for six months, not once a day for two years) and when its main result was due (at six months, not 24) [9]. The paper describes one-to-one randomisation, but the groups ended up 98 and 75; asked about it by the journal’s statistical reviewer, the authors said the imbalance may have been chance, or an unequal ratio applied without notice by the third party that ran the randomisation [4]. And the paper gives the citrate dose only approximately and the potassium not at all: the authors told the journal’s reviewers that their university’s intellectual-property office had advised against disclosing the exact dose before a patent was granted [4].

And now the limits, because they matter enormously for whether this page applies to you.

It tested a manufactured lime supplement — the paper calls it a lime-based phytochemical-rich regimen, made from lime juice and peel by a private manufacturer — not a glass of lemon water. Each once-a-day sachet carried citrate at the upper end of the range doctors prescribe as potassium citrate, with less potassium, and the paper says the supplement alkalises urine, as the citrate salts do [4]. So it is evidence about citrate therapy in a sachet, not about citrus in a glass. It was given to people who had just had kidney stones surgically removed, a group whose recurrence risk runs above 50% in five years. It says nothing whatsoever about whether citrus prevents a first stone in someone who has never had one.

And the 2021 review adds a deflating footnote for lemon specifically: “Lemon juice had a smaller protective role than orange juice” [1]. If you are drinking citrus for your kidneys, the evidence points at the orange — with two catches from the same review: orange juice raised urinary oxalate, one of the things calcium stones are made of, and it is high in carbohydrate, which in a juice means sugar [1].

One more thing from that review, which is the sort of detail that stops a tidy story: two large studies following American health professionals in the 1990s found that people who drank more grapefruit juice formed more stones, despite it having the most citrate of anything on the list [1]. Citrate is not the only thing in a fruit. But the review’s summary counts three such studies, and the third, a 2013 analysis of the same two groups plus a third, 194,095 people in all, did not confirm the grapefruit link [1][10].

What we are rating

Unsupported: that lemon water helps you lose weight. The trials that exist credit the lemon with nothing. In the trial closest to lemon water, 84 overweight Korean women were randomly assigned to a week of ‘lemon detox’ — lemon juice mixed with maple and palm syrups, and nothing else — or to a placebo juice diet matched for calories, or to their normal food. Both juice groups lost more weight, and a bigger share of their body fat, than the women eating normally; the authors put it down to “caloric restriction” [11]. Three small placebo-controlled trials of lemon compounds in capsules — powdered citrus peel, which its authors call lemon, for four weeks in 60 overweight children and teenagers, and an extract of eriocitrin, a flavonoid found in lemon, for twelve weeks in adults with prediabetes or high blood sugar — changed no measure of weight or body fat against placebo [12][13][14]. The only fat-burning mechanism we found comes from mice fed lemon-peel polyphenols as half a percent of a high-fat diet [15]. Any effect people notice belongs to the water and the habit, which we cover elsewhere.

Unsupported: that lemon alkalises you. Not on the grounds that alkalising is impossible — on the narrower and more damning grounds that when researchers measured urine pH, lemon juice did not raise it, in small studies or in a two-year randomised trial [1][6]. Of the citrus juices tested, only orange did [1][5].

Preliminary, for a specific group: lemon juice and calcium kidney stones, in people who already form them. The one randomised trial of fresh lemon juice to count new stones, about 2 fl oz (60 mL) twice a day for two years, found fewer recurrences, but not enough to rule out chance, and no rise in urinary citrate [6]; a 2026 federal evidence review rates the evidence of benefit as low [8]. The strong result belongs to a manufactured lime supplement with citrate at prescription strength, in one trial not yet repeated [4] — evidence about that kind of product, not about a glass of lemon water.

What to actually do

Drink it because you like it. That is a completely good reason and it is the one that survives this page. Water you enjoy is water you drink.

Do not buy a programme. Lemon-water detox plans, alkaline systems and pH strips are selling you a number that does not mean what they say it means — the same trick we took apart on detox teas, where nobody would name the toxin either.

If you form kidney stones, this is a real conversation to have — with a urologist. Citrate therapy is genuine clinical practice. In the three comparisons our sources describe, prescription potassium citrate raised urinary citrate more than lemonade did; one of them added the drug to lemonade rather than swapping it [1][3]. Which is right for you depends on urine chemistry that requires testing. If lemon juice comes up, know that the doses studied are far beyond a squeeze in a glass: 4 fl oz of reconstituted lemon juice a day in the 1996 lemonade study [7], and about 2 fl oz (60 mL) twice a day in the two-year trial. At that dose one person in five got heartburn, and two reported dental erosion or sensitive teeth against none without the juice, too few to tell from chance [6]. This is journalism, not medical advice.

And notice what the ritual is actually doing. A glass of water, first thing, every morning, because you have made it a small ceremony. That is a genuinely useful habit. It just does not need a theory about alkalinity to justify it, and it is a little sad that somebody decided it did.

Sources
[1] Barghouthy Y, Somani BK. Role of citrus fruit juices in prevention of kidney stone disease (KSD): a narrative review. Nutrients 2021;13(11):4117. Funding and disclosure: the authors received no support from any organisation for the work and declare no relevant conflicts. Its summary says grapefruit juice alkalised urine and that three large studies tied grapefruit juice to stones; its own data table and results section say otherwise on both. doi:10.3390/nu13114117
[2] Haleblian GE, Leitao VA, Pierre SA, Robinson MR, Albala DM, Ribeiro AA, Preminger GM. Assessment of citrate concentrations in citrus fruit-based juices and beverages: implications for management of hypocitraturic nephrolithiasis. Journal of Endourology 2008;22(6):1359–1366. Funding and disclosure: not read. The publisher shows only the abstract without a subscription, and no open copy is listed (checked 18 September 2026). doi:10.1089/end.2008.0069
[3] Kang DE, Sur RL, Haleblian GE, Fitzsimons NJ, Borawski KM, Preminger GM. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. Journal of Urology 2007;177(4):1358–1362. Funding and disclosure: the journal’s author information lists, for the paper’s senior author, a financial interest or other relationship with several companies, among them Mission Pharmacal, which makes an extended-release potassium citrate (Urocit-K), the kind of drug the paper’s comparison group took; the other five authors report nothing to disclose. doi:10.1016/j.juro.2006.11.058
[4] Dissayabutra T, Anegkamol W, Ratchanon S, et al. Lime-based supplement reduces calcium oxalate stone recurrence: a multicenter randomized controlled trial. PLoS One 2025;20(12):e0336892. Funding and disclosure: the National Research Council of Thailand and the Thailand Science Research and Innovation Fund at Chulalongkorn University; the supplement and placebo were made with the help of two private companies, Oui Heng International Healthcare and Banpong Novitat; the authors declare no competing interests. The peer-review history published with the paper records the authors’ replies on the withheld dose and the 98-to-75 split. For the registration number the paper prints, see [9]. doi:10.1371/journal.pone.0336892
[5] Hönow R, Laube N, Schneider A, Kessler T, Hesse A. Influence of grapefruit-, orange- and apple-juice consumption on urinary variables and risk of crystallization. British Journal of Nutrition 2003;90(2):295–300. Nine healthy women on a standardised diet; read in full. The paper carries no funding or conflict-of-interest statement. doi:10.1079/BJN2003897
[6] Ruggenenti P, Caruso MR, Cortinovis M, et al. Fresh lemon juice supplementation for the prevention of recurrent stones in calcium oxalate nephrolithiasis: a pragmatic, prospective, randomised, open, blinded endpoint (PROBE) trial. EClinicalMedicine 2022;43:101227. Registered on ClinicalTrials.gov as NCT01217372, first posted in October 2010, after enrolment began in July 2009; the record matches the published trial’s design and size. Funding and disclosure: the study received no funding; one author reported personal fees and speaker honoraria from several drug companies, and the other authors had nothing to disclose. doi:10.1016/j.eclinm.2021.101227
[7] Seltzer MA, Low RK, McDonald M, Shami GS, Stoller ML. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. Journal of Urology 1996;156(3):907–909. Twelve patients, six days; read in its published abstract. The full text is behind the journal’s paywall, and neither PubMed nor the journal’s page lists funding or disclosures (checked 18 September 2026). doi:10.1016/S0022-5347(01)65659-3
[8] Asher GN, Viprakasit DP, Aymes SE, et al. Recurrent Nephrolithiasis in Adults and Children: Comparative Effectiveness of Preventive Medical Strategies. Systematic review, AHRQ Publication No. 26-EHC005. Rockville, MD: Agency for Healthcare Research and Quality; January 2026. Literature searched to May 2025; read in full on the NCBI Bookshelf. Its journal version, Annals of Internal Medicine 2026;179(5):696–707, searched to December 2025; its summary gives alkali therapy the same low grade and adds “There may be increased minor adverse events with lemon juice”. Its reference list includes [4], but we could not read its full text (the publisher’s site refused automated access and showed a browser check), so whether it pooled that trial we cannot say. Funding: the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute. doi:10.23970/AHRQEPCSRKIDNEY doi:10.7326/ANNALS-25-04452
[9] Trial registry records for [4], read 18 September 2026. The number printed in [4], TCTR20250530001 on the Thai Clinical Trials Registry, is “Flavonoid-Rich Lime Extract Attenuates Albuminuria in Diabetic Nephropathy”: three six-month arms (a lime extract, a citrate solution and a placebo), 100 planned, first enrolment 1 July 2021, registered 30 May 2025 and marked as not prospectively registered; read on the registry’s own site and on the World Health Organization’s trial registry platform. ClinicalTrials.gov NCT03258190, “Lime Powder Regimen (LPR) for Prevention of Renal Stone Recurrence”, sponsored by Chulalongkorn University: start July 2014, first posted August 2017, completed June 2018, 137 enrolled, participants masked, twice-daily dosing for six months, main outcome at six months. Searches of both registries found no other lime-powder stone trial. The January 2026 federal review [8] lists a two-year lime-powder stone trial from the same university with its registry number “Not reported”. thaiclinicaltrials.org; clinicaltrials.gov
[10] Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Soda and other beverages and the risk of kidney stones. Clinical Journal of the American Society of Nephrology 2013;8(8):1389–1395. Funding and disclosure: US National Institutes of Health research grants; one author is the journal’s editor-in-chief and an author and section editor of UpToDate, a clinical reference; the others have nothing to disclose. doi:10.2215/CJN.11661112
[11] Kim MJ, Hwang JH, Ko HJ, Na HB, Kim JH. Lemon detox diet reduced body fat, insulin resistance, and serum hs-CRP level without hematological changes in overweight Korean women. Nutrition Research 2015;35(5):409–420. Read in its published abstract; the full text is behind the publisher’s paywall. Funding: Cencorp Korea Co. Ltd., according to the publisher’s funding record; the Lemon Detox brand’s own website lists Cencorp Korea as its distributor in Korea (checked 18 September 2026). doi:10.1016/j.nutres.2015.04.001
[12] Hashemipour M, Kargar M, Ghannadi A, Kelishadi R. The effect of Citrus aurantifolia (lemon) peels on cardiometabolic risk factors and markers of endothelial function in adolescents with excess weight: a triple-masked randomized controlled trial. Medical Journal of the Islamic Republic of Iran 2016;30:429. The species named, Citrus aurantifolia, is the fruit that [4] calls lime. Funding and disclosure: a thesis funded by Isfahan University of Medical Sciences; no conflicts declared. It has no DOI. PMC5307599
[13] Ribeiro CB, Ramos FM, Manthey JA, Cesar TB. Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: a double-blind, randomized, controlled study. Phytotherapy Research 2019;33(7):1921–1933. Funding and disclosure: funded by Ingredients by Nature, which supplied the extract; the paper says the sponsors had no role in the design, execution, interpretation or writing of the study. doi:10.1002/ptr.6386
[14] Cesar TB, Ramos FMM, Ribeiro CB. Nutraceutical eriocitrin (Eriomin) reduces hyperglycemia by increasing glucagon-like peptide 1 and downregulates systemic inflammation: a crossover-randomized clinical trial. Journal of Medicinal Food 2022;25(11):1050–1058. Funding and disclosure: funded by Ingredients by Nature, which supplied the extract; the authors report no conflict of interest, and the paper says the sponsors had no role in the design, execution, interpretation or writing of the study. doi:10.1089/jmf.2021.0181
[15] Fukuchi Y, Hiramitsu M, Okada M, et al. Lemon polyphenols suppress diet-induced obesity by up-regulation of mRNA levels of the enzymes involved in beta-oxidation in mouse white adipose tissue. Journal of Clinical Biochemistry and Nutrition 2008;43(3):201–209. A study in mice. Funding and disclosure: the paper carries no funding statement; the lemon-peel extract was supplied by Pokka Corporation, a Japanese company, and one author’s affiliation is its research and development department. doi:10.3164/jcbn.2008066
Correction · 18 September 2026

An independent editorial review on 18 September 2026 found that this page overstated what lemon does for kidney stones. We rated citrus citrate for stones “genuinely supported” and said lemon had a real use there, while leaving out the one randomised trial of fresh lemon juice: 203 people over two years, in which fewer stones came back but not enough to rule out chance, urinary citrate did not rise, and one in five got heartburn. A January 2026 evidence review for the US Agency for Healthcare Research and Quality grades the evidence for lemon juice, and for citrate therapy as a whole, as low. We also called the 2025 lime trial “properly designed”. Its product is a manufactured supplement with citrate at prescription strength; the registration number printed in the paper leads to a different trial, the closest registration we found differs from it in size, blinding, dosing and timing, its groups ended up 98 and 75 under a one-to-one design, and the exact dose was withheld pending a patent. The page now reports all of this, and rates lemon juice for stones as preliminary.

Also corrected. We said grapefruit juice alkalises urine, quoting the review’s summary; the review’s own table shows no significant rise in any of its three grapefruit studies, or for lime, and only orange juice did it. We said three large studies found grapefruit juice raised stone risk; two did, and a larger 2013 analysis of the same groups did not confirm it. We said there was no trial of lemon and weight; there are four small ones, and none credits the lemon with any weight lost. We said the prescription drug beat lemonade in “the one comparison we have”; our own sources describe three. The evidence panel said our sources’ funding was not stated; the papers state it, and the panel now lists every tie by role, including a senior author’s relationship with a maker of prescription potassium citrate. The replication row now says the lemon results are mixed, as the review itself does. The first two steps of the provenance chain ran backwards in time and now begin with the 1996 lemonade study; the step we could not trace now says so, and the claim itself is now stated in our words rather than in quotation marks, because we found no one to quote. The rating is unchanged: Unsupported.